Interested in volunteering for a clinical study? Please fill out the following form so that we may determine your eligibility for one of ACMR’s ongoing or upcoming studies.
Schizophrenia is defined by the National Institute of Mental Health as “a chronic and severe mental disorder that affects how a person thinks, feels, and behaves.” Schizophrenia can greatly impact an individual’s ability to perceive, understand and interact with the outside world.
The Diagnostic and Statistical Manual of Mental Disorders requires two or more of the following symptoms to be present for a diagnosis of schizophrenia:
Schizophrenia can be challenging to treat. Often, it is difficult to ensure schizophrenics take all of their medication. Schizophrenics may feel as if their symptoms have disappeared before their prescribed medication has ran its course, and may decide to discontinue only to fall back into symptomatic schizophrenia again.
Researchers are attempting to develop methods to ensure schizophrenics take their prescribed medication, such as extended-release pills or injections that stay in a patient's system for longer than conventional medication.
Researchers are also attempting to uncover more about the origins of schizophrenia to better diagnose and treat the disorder. New studies suggest that a combination of environmental and genetic factors may play a part in the disorder’s development.
The Atlanta Center for Medical Research was founded in 1982 by Dr. Robert A. Riesenberg and is now one of the largest and most respected medical research institutions in the country. ACMR’s 150,000-square-foot, state-of-the-art, open-source research facility is a game changer for the medical research world. ACMR’s practices set the standard for medical research, facilitating the availability of safe and effective medicine to people everywhere.
how visitors behave on our website. The information we collect will
not be linked with a visitor's identity.